Yes
Phonekeo, S. and Kounnavong, S. and Vonglokham, M. and Siengsounthone, L. and Homsana, A. and Gummin, S. and Vounatsu, P. and Nittiyanant, P. and Worawichawong, S. and Aekplakorn, W. and Odermatt, P. and Sayasone, S..
(2023)
Intestinal helminth infections and associated risk factors among adults in the Lao People's Democratic Republic.
Infect Dis Poverty, 12.
p. 61.
Falcoz, C. and Guzy, S. and Kovač, J. and Meister, I. and Coulibaly, J. and Sayasone, S. and Wesche, D. and Lin, Y. W. and Keiser, J..
(2022)
R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with; Schistosoma mansoni; and; S. haematobium; and Lao adults infected with; Opisthorchis viverrini.
J Pharmacokinet Pharmacodyn, 49 (3).
pp. 293-310.
Hofmann, D. and Smit, C. and Sayasone, S. and Pfister, M. and Keiser, J..
(2022)
Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling.
Clin Transl Sci, 15 (3).
pp. 700-708.
Hürlimann, E. and Keller, L. and Patel, C. and Welsche, S. and Hattendorf, J. and Ali, S. M. and Ame, S. M. and Sayasone, S. and Coulibaly, J. T. and Keiser, J..
(2022)
Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with; Trichuris trichiura; in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial.
The Lancet infectious diseases, 22 (1).
pp. 123-135.
Smit, C. and Hofmann, D. and Sayasone, S. and Keiser, J. and Pfister, M..
(2022)
Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen.
Clinical pharmacokinetics, 61.
pp. 123-132.
Falcoz, C. and Guzy, S. and Kovac, J. and Meister, I. and Coulibaly, J. and Sayasone, S. and WEsche, D. and Lin, Y. W. and Keiser, J..
(2022)
Correction to: R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini.
J Pharmacokinet Pharmacodyn, 49 (3).
p. 395.
Keller, L. and Welsche, S. and Patel, C. and Sayasone, S. and Ali, S. M. and Ame, S. M. and Hattendorf, J. and Hürlimann, E. and Keiser, J..
(2021)
Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania.
PLoS Negl Trop Dis, 15 (6).
e0009561.
Keller, L. and Hürlimann, E. and Patel, C. and Welsche, S. and Sayasone, S. and Ali, S. M. and Ame, S. M. and Coulibaly, J. T. and Keiser, J..
(2021)
Insights gained from conductinga randomised controlled trial onIvermectin-albendazole against Trichuris trichiura in Côte d'Ivoire, Lao PDR and Pemba Island.
Advances in parasitology, 111.
pp. 253-276.
Hofmann, D. and Sayasone, S. and Sengngam, K. and Chongvilay, B. and Hattendorf, J. and Keiser, J..
(2021)
Efficacy and safety of ascending doses of moxidectin against; Strongyloides stercoralis; infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial.
Lancet Infect Dis, 21 (8).
pp. 1151-1160.
Hofmann, D. and Sayasone, S. and Keiser, J..
(2021)
Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos.
J Chromatogr B Analyt Technol Biomed Life Sci, 1166.
p. 122556.
Patel, C. and Keller, L. and Welsche, S. and Hattendorf, J. and Sayasone, S. and Ali, S. M. and Ame, S. M. and Coulibaly, J. T. and Hürlimann, E. and Keiser, J..
(2021)
Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania.
EClinicalMedicine, 32.
p. 100724.
